- MarketWatch•22 minutes ago
Express Scripts’ stock takes a dive after the pharmacy benefit manager became the latest victim of bearish tweets by noted short seller Andrew Left’s Citron Research.
- Investor's Business Daily•24 minutes ago
If Trump wants to crack down on drug pricing, perhaps he might start with Express Scripts, Citron Research suggested Thursday.
- CNBC•57 minutes ago
Citron Research tweeted that Express Scripts is the "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct.
ESRX : Summary for Express Scripts Holding Company - Yahoo Finance
Express Scripts Holding Company (ESRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||72.25 x 500|
|Ask||72.29 x 600|
|Day's Range||68.00 - 75.99|
|52 Week Range||64.46 - 89.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.72|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|